LBP-BPI (Incyte Corporation)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLBP-BPI (Incyte Corporation)
Drug Alias NameBPI-LBPNCY-118
ClassificationBiologics
Mechanisms of ActionCell membrane permeability enhancers
TargetsNot applicable
Therapy Area/IndicationsShock, SepticGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXoma CorpIncyte Corp
Active IndicationsN/A
Inactive IndicationsShock, SepticGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A